EDIT
Editas MedicineยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
EDIT fundamentals
Editas Medicine (EDIT) released its earnings on Nov 10, 2025: revenue was 7.54M (YoY +12260.66%), beat estimates; EPS was -0.28 (YoY +62.67%), beat estimates.
Revenue / YoY
7.54M
+12260.66%
EPS / YoY
-0.28
+62.67%
Report date
Nov 10, 2025
EPS
Revenue
Revenue & Expenses
EDIT has released its 2025 Q3 earnings report, with revenue of 7.54M, reflecting a YoY change of 12265.57%, and net profit of -25.12M, showing a YoY change of 59.58%. The Sankey diagram below clearly presents EDIT's revenue sources and cost distribution.
Key Indicators
Editas Medicine (EDIT) key financial stats and ratios, covering profitability, financial health, and leverage.
Editas Medicine (EDIT)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Editas Medicine (EDIT)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Editas Medicine (EDIT)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Editas Medicine (EDIT) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Editas Medicine (EDIT) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Editas Medicine's latest dividend and current dividend yield?What does Editas Medicine do and what are its main business segments?What is Editas Medicine's gross profit margin?What factors drove the changes in Editas Medicine's revenue and profit?What were the key takeaways from Editas Medicine's earnings call?Did Editas Medicine beat or miss consensus estimates last quarter?What guidance did Editas Medicine's management provide for the next earnings period?What is the market's earnings forecast for Editas Medicine next quarter?
